ArticlePeerJ2021

Inhibition of SARS-CoV-2 infection in human iPSC-derived cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoarchitecture and beating.

José Alexandre Salerno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.